X.Org Foundation Competitors

OVERVIEW: Euclid Techlabs provides innovative solutions in the fields of charged particle beam physics through materials science. Founded in 2003, we have successfully completed thousands of collaborative programs totaling with the leading energy (DoE), defense (DHS), and health (NIH) agencies, working within or alongside of with their representative laboratories. These partnering laboratories are breaking technical barriers daily and require cutting-edge technologies to achieve their goals. We equip our partners with technology that is focused on their goals by applying our deep, diverse technical expertise and rapid prototyping capabilities. Innovation continues through our agile product development to deliver commercial products to high tech industries. Please see our website for the listing of global laboratory collaborations and commercial products. OUR PASSION: We take a highly multidisciplinary approach starting from first principles to equip our partners with the best solutions available. Incorporating broader market and customer perspectives, we continue to innovate on these solutions to create commercial products for high tech industries. OUR EXPERTISE: We have a diverse team of engineers and scientists from all over the world, bringing unique experiences from high energy (accelerator) physics, power electronics materials, energy conversion materials, rf design & simulation, field emission cathodes, charged particle beam simulation, and industrial equipment design. Core products involve beam physics experimentation (accelerators, TWT, x-ray & klystrons), electron microscope enhancement (ultrafast electron microscope pulser), suitcase accelerators, and high brightness electron guns. Euclid Beamlabs is a subsidiary of Techlabs, exclusively focused on developing new materials.

Sightsys is ditrubution company for the local embedded systems in Israel Sightsys is Israel's official distributor of professional embedded software development and testing tools. We've helped Israeli engineering teams ship reliable, certified, and high-performance embedded products across automotive, aerospace, defense, medical devices, industrial automation, telecommunications, and consumer electronics. We represent leading global vendors as their authorized Israeli partner: • IAR Embedded Workbench — qualified C/C++ compilers and IDE for ARM, RISC-V, and many other architectures, including Functional Safety Edition for ISO 26262, DO-178C, IEC 62304, IEC 61508, EN 50128. • SEGGER — J-Link debug probes, J-Trace, SystemView, Flasher production programmers, embOS, embOS-SAFE (TÜV-certified), emNet, emFile. • SYSGO PikeOS — certified safety hypervisor for DO-178C DAL A, ISO 26262 ASIL D, EN 50128 SIL 4, IEC 61508 SIL 3, Common Criteria EAL 5+. • Kvaser — CAN, CAN FD, CANopen, J1939 interface hardware and software. • Axivion — static code analysis with architecture verification for MISRA-C, MISRA-C++, AUTOSAR, CWE. • QA Systems Cantata — automated unit testing with MC/DC coverage for safety-critical software. • Solid Sands SuperTest and SuperGuard — compiler and library qualification for safety standards. • Corelis — JTAG boundary-scan controllers and ScanExpress test development services. • Percepio — runtime monitoring and RTOS awareness for ARM Cortex-M and other targets. • Embedded Office Flexible Safety RTOS — pre-certified kernel for IEC 61508, ISO 26262, IEC 62304, EN 50128. Our services go beyond distribution. The Sightsys team writes JTAG boundary-scan test scripts, qualifies toolchains for certification audits, delivers online training webinars, provides Hebrew technical support, and helps customers calculate ROI versus open-source alternatives. Sightsys is ISO 9001:2015 certified, headquartered in Petah Tikva.

The International Society for Mannosidosis and Related Diseases (ISMRD) is a 501(c)(3) not-for-profit organization based in California, USA. ISMRD is the leading advocate for families worldwide affected by a Glycoprotein Storage Disease (Alpha Mannosidosis, Aspartylglucosaminuria, Beta Mannosidosis, Fucosidosis, Galactosialidosis, Mucolipidosis Alpha/Beta, Mucolipidosis III Gamma, Sialidosis, Schindler Disease). Through partnerships built with medicine, science and industry, we seek to detect and cure these diseases, and to provide a global network of support and information We seek a future in which children with Glycoprotein Storage Diseases can be detected early, treated effectively, and go on to live long, healthy and productive lives; a future where doctors and other clinicians are knowledgeable of and able to detect these genetic defects efficiently and with accuracy. In our vision the public at-large will have a general knowledge and understanding of these diseases, and will actively strive to prevent their occurrence. Ultimately, we envision a world where there will no longer be a need for our organization or others like it to exist.